GSC
TBPH icon

Ground Swell Capital’s Theravance Biopharma TBPH Stock Holding History

Ground Swell Capital’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Buy
+49
New +$1.42K ﹤0.01% 2199

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
FAM
Foundation Asset Management White Plains, New York $116M AUM 31.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ground Swell Capital's TBPH Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Theravance Biopharma (TBPH) in Q3 2014: 49 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2199 among its holdings.

91 funds tracked by Wall St. Rank hold TBPH as of Q3 2014.

  • Ground Swell Capital held 49 shares of Theravance Biopharma worth $1K as of Q3 2014.
  • Theravance Biopharma was a new Ground Swell Capital position in Q3 2014.
  • Theravance Biopharma made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2199 holding.
  • 91 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.